The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 16,225,278 | 886,143 | SH | SOLE | 886,143 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 10,364,734 | 577,101 | SH | SOLE | 577,101 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 4,952,681 | 10,074 | SH | SOLE | 10,074 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 10,531,972 | 112,473 | SH | SOLE | 112,473 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 9,094,434 | 1,219,093 | SH | SOLE | 1,219,093 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 6,955,803 | 982,458 | SH | SOLE | 982,458 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 16,622,379 | 64,676 | SH | SOLE | 64,676 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 9,704,929 | 109,685 | SH | SOLE | 109,685 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 17,310,296 | 1,775,415 | SH | SOLE | 1,775,415 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 33,504,459 | 1,126,579 | SH | SOLE | 1,126,579 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 16,765,684 | 1,124,459 | SH | SOLE | 1,124,459 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 14,587,649 | 495,168 | SH | SOLE | 495,168 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 12,846,796 | 111,045 | SH | SOLE | 111,045 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 10,892,578 | 994,756 | SH | SOLE | 994,756 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM | 471871103 | 970,910 | 1,387,015 | SH | SOLE | 1,387,015 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 17,432,669 | 1,810,246 | SH | SOLE | 1,810,246 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 944,756 | 40,066 | SH | SOLE | 40,066 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 3,132,782 | 136,743 | SH | SOLE | 136,743 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 14,352,569 | 118,401 | SH | SOLE | 118,401 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 11,731,710 | 807,969 | SH | SOLE | 807,969 | 0 | 0 |